Financial comparisons Marker Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
1.330 ^USD	-1.48%		-3.62%	-10.74%

11-14	Marker Therapeutics Q3 net loss narrows to $2 mln	RE
11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
MARKER THERAPEUTICS, INC.	6.59M	-162.82%	-168.69%	-	-	-
LONZA GROUP AG	7.25B	9.67%	17.9%	6.77%	3.48%	1.5x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	11.07%	4.42%	-3.99x
CELLTRION, INC.	2.41B	11.88%	13.83%	2.46%	2.14%	1.28x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	11.46%	4.17%	2.2x
IONIS PHARMACEUTICALS, INC.	944M	-40.36%	-40.47%	-70.72%	-11.67%	5.33x
ABIVAX	12.94M	-1,409.6%	-1,383.2%	-148.95%	-	0.4x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
BLUEPRINT MEDICINES CORPORATION	509M	-13.19%	-41.67%	-31.26%	-21.6%	-0.14x
QIAGEN N.V.	1.98B	4.23%	28.66%	13.31%	8.32%	0.34x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
PHARMARON BEIJING CO., LTD.	1.68B	14.61%	17.14%	13.7%	7.12%	1.33x
Average	3.72B	-93.32%	-85.36%	-5.63%	3.01%	-3.06x
Weighted average by Cap.	5.29B	-49.3%	-42.12%	1.8%	3.37%	-1.47x